These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2572941)

  • 1. Inhibition of HBV DNA replication by ganciclovir in patients with AIDS.
    Locarnini S; Guo K; Lucas R; Gust I
    Lancet; 1989 Nov; 2(8673):1225-6. PubMed ID: 2572941
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary evidence that azidothymidine does not affect hepatitis B virus replication in acquired immunodeficiency syndrome (AIDS) patients.
    Farraye FA; Mamish DM; Zeldis JB
    J Med Virol; 1989 Dec; 29(4):266-7. PubMed ID: 2621453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of lamivudine on the replication of hepatitis B virus in a patient with acquired immunodeficiency syndrome].
    Gil H; Vuitton DA; Rozenbaum A; Bresson-Hadni S; Dupond JL
    Gastroenterol Clin Biol; 1997; 21(12):997-8. PubMed ID: 9587567
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocycles.
    Edwards TC; Lomonosova E; Patel JA; Li Q; Villa JA; Gupta AK; Morrison LA; Bailly F; Cotelle P; Giannakopoulou E; Zoidis G; Tavis JE
    Antiviral Res; 2017 Jul; 143():205-217. PubMed ID: 28450058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro.
    McMillan JS; Shaw T; Angus PW; Locarnini SA
    Hepatology; 1995 Jul; 22(1):36-43. PubMed ID: 7601429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
    Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
    World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
    Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
    World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB.
    Biermer M; Puro R; Schneider RJ
    J Virol; 2003 Apr; 77(7):4033-42. PubMed ID: 12634363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-phase arrest after vincristine treatment may promote hepatitis B virus replication.
    Xu L; Tu Z; Xu G; Hu JL; Cai XF; Zhan XX; Wang YW; Huang Y; Chen J; Huang AL
    World J Gastroenterol; 2015 Feb; 21(5):1498-509. PubMed ID: 25663769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
    Hu K; Huang Y; Mu J; Cheng Z; Zhu X
    Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
    Li GQ; Xu WZ; Wang JX; Deng WW; Li D; Gu HX
    World J Gastroenterol; 2007 Apr; 13(16):2324-7. PubMed ID: 17511031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of hepatitis B virus replication by 2',3'-dideoxyguanosine, 2',3'-dideoxyinosine, and 3'-azido-2',3'-dideoxythymidine in 2.2.15 (PR) cells.
    Aoki-Sei S; O'Brien MC; Ford H; Fujii H; Gilbert DA; Cooney DA; Johns DG; Broder S; Mitsuya H
    J Infect Dis; 1991 Nov; 164(5):843-51. PubMed ID: 1940465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive effects of a major component of green tea, epigallocathechin-3-gallate, on hepatitis-B virus DNA replication.
    Karamese M; Aydogdu S; Karamese SA; Altoparlak U; Gundogdu C
    Asian Pac J Cancer Prev; 2015; 16(10):4199-202. PubMed ID: 26028072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on inhibitory effect of CpG-ODN on HBV replication in vitro].
    Li N; Fan XG; Chen ZH; Zhu C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):103-5. PubMed ID: 15629096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
    Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ
    Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effects of co-cinobufotalin oral liquor on hepatitis B in vitro].
    Liu Z; Fu XX; Zhang NL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Dec; 16(12):738-40. PubMed ID: 9772592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hepatitis B virus activities of purine derivatives of oxetanocin A.
    Nagahata T; Ueda K; Tsurimoto T; Chisaka O; Matsubara K
    J Antibiot (Tokyo); 1989 Apr; 42(4):644-6. PubMed ID: 2722678
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
    Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
    Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro].
    Wu JM; Lin JS; Xie N; Qiu GF; Hu XM
    Yao Xue Xue Bao; 2005 Sep; 40(9):825-9. PubMed ID: 16342685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of replication of human hepatitis B virus].
    Tsibinogin VV; Kraevskiĭ AA; Bibilashvili RSh; Gren EIa; Kiselev LL
    Mol Biol (Mosk); 1989; 23(4):983-7. PubMed ID: 2586511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.